What are the best treatments for Tetralogy Of Fallot?

Tetralogy of Fallot is a congenital heart defect that almost universally requires surgical repair, typically performed in early infancy to correct the four structural cardiac abnormalities. While long-term follow-up is essential, most individuals with Tetralogy of Fallot lead active, productive lives following successful surgical intervention.

What are the primary surgical treatments for Tetralogy of Fallot?

The definitive treatment for Tetralogy of Fallot is open-heart surgery to close the ventricular septal defect and relieve the pulmonary artery obstruction. Most surgeons perform this complete repair during the first six months of life. In some cases, if a newborn is too fragile, a temporary "shunt" procedure may be performed first to increase blood flow to the lungs until a complete repair is possible.

What medications are used in the management of Tetralogy of Fallot?

Medications are rarely a permanent cure for Tetralogy of Fallot but are used to manage symptoms or support the heart post-surgery. Common prescriptions include:

• Beta-blockers (e.g., propranolol): Often used to manage "Tet spells" (hypercyanotic episodes) by relaxing the heart muscle.


• Diuretics (e.g., furosemide): Prescribed if there are signs of heart failure or fluid retention.


• ACE inhibitors (e.g., lisinopril): Sometimes used to manage long-term blood pressure or heart function in patients with residual issues.

Which specialists are involved in a multidisciplinary care team?

Because Tetralogy of Fallot is a lifelong condition, patients require a multidisciplinary approach to care. Your team should ideally include:

• Pediatric/Adult Congenital Cardiologist: The lead coordinator for your long-term cardiac health.


• Congenital Cardiothoracic Surgeon: For initial repairs and potential later valve replacements.


• Electrophysiologist: To monitor for and treat arrhythmias, which can occur later in life.


• Clinical Geneticist: To evaluate for associated conditions, such as 22q11.2 deletion syndrome, which occurs in approximately 15% of cases.

How does treatment effectiveness vary between patients?

The long-term outlook for Tetralogy of Fallot is generally excellent, with survival rates exceeding 95% into adulthood. However, effectiveness varies based on the severity of the initial defect, the timing of the surgery, and the presence of residual pulmonary valve regurgitation. At DiseaseMaps.org, 362 members share experiences regarding their unique surgical journeys and post-operative management, emphasizing that every patient’s anatomy requires a personalized care plan.

Next steps

• Schedule regular follow-up imaging (MRI or echocardiogram) with a congenital heart specialist.


• Consult your cardiologist before starting any new exercise program or strenuous physical activity.


• Connect with the 362 members at DiseaseMaps.org to share experiences and coping strategies.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult your personal healthcare team for diagnosis and treatment decisions.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Tetralogy of Fallot


• Orphanet: Tetralogy of Fallot (ORPHA:333)


• American Heart Association (AHA): Congenital Heart Defects


• OMIM: Tetralogy of Fallot (Entry #187500)